about
Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava.MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer.Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyPreoperative C-Reactive Protein Values as a Potential Component in Outcome Prediction Models of Metastasized Renal Cell Carcinoma Patients Receiving Cytoreductive Nephrectomy.Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression.Maintenance monotherapy with Gemcitabine following cisplatin-based primary combination chemotherapy in surgically treated advanced urothelial carcinoma: A matched-pair single institution analysis.Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CTMucin-Poor Mucinous Tubular and Spindle Cell Carcinoma of the Kidney Presented with Multiple Metastases Two Years after Nephrectomy: An Atypical Behaviour of a Rare, Indolent Tumour.Diagnosis and Clinical Management of Ruptured Ileocecal Pouches for Continent Cutaneous Urinary Diversion.[How should hormone therapy for castration-resistant prostate cancer be continued?]Long-Term Outcome of Nephron-Sparing Surgery Compared to Radical Nephrectomy for Renal Cell Carcinoma ≥4 cm - A Matched-Pair Single Institution AnalysismiR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1The Role of Magnetic Resonance Imaging in the Diagnosis of Penile Fracture in Real-Life Emergency Settings: Comparative Analysis with Intraoperative FindingsmiR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivoCognitive Status and Functional Dexterity as Outcome Predictors Following Urinary Diversion: A Combined Retrospective and Prospective Observational Study
P50
Q34287632-631BD216-0DE7-423F-B6F2-8E236B824FB3Q34381328-E189198F-3208-4D9A-A293-6C326FEA3DCBQ37214430-3E142210-A9F2-4826-93F8-BDEE1DC3E8A6Q38720864-0AC8C0A2-83E8-49CF-AD81-FB3F7B0034D5Q38825551-281AFB8B-C6A2-4753-B63D-4F4F3AEA69E9Q38881827-CCFDEC61-3F5A-4E15-957B-F48AD3A13DBDQ39017421-DC16FD34-6719-45A9-A13F-E7413B6E393BQ39922053-D72DC845-C6BB-4547-B206-76935A3F569EQ48213930-07D7DF0E-1CF0-4DD9-9461-650DAE5F0D0AQ51117138-7B83FFDB-FF5A-4781-AB43-B7F0C9F643A0Q57135372-A1C7E3C9-2004-4248-B795-C0514B16D3DFQ88088654-97345127-301D-4F95-8674-CC8FC657BFECQ91900221-F111EE48-A406-472B-B2BF-E53E333459BCQ92166445-E7D74A5A-D406-4931-A64F-46A4770BD43AQ93020115-21BCC303-2B1D-439A-9384-9323BD03668FQ93274357-B2FD64FB-BF87-4320-AFDC-BA7399ADDFCC
P50
description
researcher ORCID ID=0000-0002-1154-0964
@en
wetenschapper
@nl
name
Markus Krebs
@ast
Markus Krebs
@en
Markus Krebs
@nl
type
label
Markus Krebs
@ast
Markus Krebs
@en
Markus Krebs
@nl
prefLabel
Markus Krebs
@ast
Markus Krebs
@en
Markus Krebs
@nl
P106
P31
P496
0000-0002-1154-0964